2-Dodecyl-1,3-propanedithiol
Common Name: |
2-Dodecyl-1,3-propanedithiol |
IUPAC Name: |
2-dodecylpropane-1,3-dithiol |
Molecular Formula: |
C15H32S2 |
SMILES: |
CCCCCCCCCCCCC(CS)CS |
Inchi: |
1S/C15H32S2/c1-2-3-4-5-6-7-8-9-10-11-12-15(13-16)14-17/h15-17H,2-14H2,1H3 |
Inchi Key: |
PFMGYFXEWXMNIK-UHFFFAOYSA-N |
Cas No: |
_ |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
1 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
276.54 |
Mass (g/mol) |
276.195 |
Molar Refractivity |
90.08 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
13 |
Rings |
|
TPSA |
77.60 |
Hetero Atoms |
2 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
5.773 |
iLOGP |
4.31 |
XLOGP3 |
7.37 |
WLOGP |
5.77 |
MLOGP |
5.28 |
ESOL Log S |
-5.34 |
ESOL Solubility (mg/ml) |
0.001 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-8.83 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-5.80 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-2.75 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.904 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.199 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |